Bevacizumab is thought to normalize tumor vasculature and restore the blood–brain barrier,
decreasing enhancement and peritumoral edema. Conventional measurements of tumor …

Purpose Diffusion-weighted magnetic resonance imaging (DWI) and fluorodeoxyglucose
positron emission tomography/computed tomography (FDG PET/CT) are oncological …

Purpose: To evaluate regional and temporal changes in apparent diffusion coefficient (ADC)
and T2 relaxation during radiation therapy (RT) in patients with low and intermediate risk …

PURPOSE: In the current study we examined the ability of diffusion MRI (dMRI) to predict
pathologic response in pancreatic cancer patients receiving neoadjuvant chemoradiation …

Diffusion-weighted magnetic resonance imaging (DWI) is increasingly being used to assess
tumour response to a variety of anticancer treatments. The technique is quick to perform …

Magnetic resonance (MR) imaging provides excellent soft tissue differentiation and in vivo
assessment of physiologic and metabolic properties of tissue. As new and more aggressive …

Direct monitoring of cell death (ie, apoptosis and necrosis) during or shortly after treatment is
desirable in all cancer therapies to determine the outcome. Further differentiation of …

Tumor responses to therapy in the clinic are still evaluated primarily from non-invasive
imaging measurements of reductions in tumor size. This approach, however, lacks sensitivity …

Molecular imaging is commonly defined as the ability to localize and measure biologic
processes on the cellular and molecular level in the living organism. An imaging probe that …

Purpose To evaluate diffusion weighted MRI (DW-MR) as a response metric for assessment
of neoadjuvant chemotherapy (NAC) in patients with primary breast cancer using …